-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Hundreds of cancer-related genes play different roles in the pathogenesis than scientists expected
It has long been known that so-called tumor suppressor genes can prevent cell growth and prevent the spread of cancer cells
Now, the team of Stephen Elledge, a researcher at the Howard Hughes Medical Institute, has discovered a surprising new role for many of these defective genes
The relevant research was found in Science on September 16, 2021
The traditional view is that for the vast majority of tumor suppressor genes, mutations can cause cells to grow and divide wantonly, beyond control
Elledge's new paper provides some answers
"These results reveal an unexpected relationship between tumor suppressor genes and the immune system," said HHMI researcher Bert Vogelstein (who was not involved in the study)
Clear melanoma
Of course, the idea that tumors can evade the body's defense system is not new
Checkpoint inhibitors are now big sellers
CRISPR technology
Elledge has a hunch that defective tumor suppressor genes are not just accelerating cell growth
Genetic analysis revealed abundant mutant genes in tumors and may play a role in tumor formation
Elledge's method reveals many different genes, and tumors can mutate to escape the body's defenses
Their research paints a thought-provoking picture of a rapid and fierce evolutionary arms race between cancer cells and the immune system.
In general, Elledge hopes that his discovery will open a new door to the treatment of cancer
Original search:
Timothy D.
DOI 10.